Lataa...
The Pharmacology of T Cell Therapies
Adoptive cellular therapy using T cells with tumor specificity derived from either natural T cell receptors (TCRs) or an artificial chimeric antigen receptor (CAR) has reached late phase clinical testing, with two CAR T cell therapies achieving regulatory approval within the United States in 2017. T...
Tallennettuna:
| Julkaisussa: | Mol Ther Methods Clin Dev |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Gene & Cell Therapy
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5852291/ https://ncbi.nlm.nih.gov/pubmed/29552577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.01.010 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|